Metastatic Adenocarcinoma
Patient Internal ID: 500181945
C56 Malignant Neoplasm of Ovary
October 2021
Ovarian Adenocarcinoma pT3cN1M0 G3 stage IIIC. BRAC2 (+) Gene mutation in Exon 17. Post operation (October 2001), Chemotherapy (2002). From 2006 disease progression: cT3cN2M1 stage IV. Progression seen in 2006, 2012, 2016, 2017, and 2019 with Metastasis in Left Lung and Abdomen. Disease progression (January 2020): Metastases in Left Lung, Abdomen.
Surgery (Hysterectomy), Chemotherapy (Cisplatin /Cyclophosphamide), Chemotherapy (Carboplatin/Paclitaxel), Chemotherapy (Cisplatin/Gemcitabine), Target therapy (Olaparib), Radiation Therapy, Chemotherapy (Topotecan), Chemotherapy (Gemcitabine).
The prognosis of advanced Ovarian Adenocarcinoma with BRAC2 mutation has a median survival of 23 months from diagnosis.
Autologous DCV (6 doses) and CIK (8 doses). Additionally, the patient received Umbilical Cord Blood Derived NK cells (24 doses) and Mistletoe Therapy.
The patient is alive and under active treatment with Chemotherapy (Gemcitabine). She has survived 23 years so far and 17 years since disease progression. It can be concluded that Immunotherapy , alongside Surgery and Chemotherapies, has extended patient survival by around 2 decades compared with median survival.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-advertisement | session | Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category . |
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
CookieLawInfoConsent | 1 year | Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie. |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.